There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This article has been retracted by Hindawi following an investigation undertaken by
the publisher [1]. This investigation has uncovered evidence of one or more of the
following indicators of systematic manipulation of the publication process:
Discrepancies in scope
Discrepancies in the description of the research reported
Discrepancies between the availability of data and the research described
Inappropriate citations
Incoherent, meaningless and/or irrelevant content included in the article
Peer-review manipulation
The presence of these indicators undermines our confidence in the integrity of the
article's content and we cannot, therefore, vouch for its reliability. Please note
that this notice is intended solely to alert readers that the content of this article
is unreliable. We have not investigated whether authors were aware of or involved
in the systematic manipulation of the publication process.
In addition, our investigation has also shown that one or more of the following human-subject
reporting requirements has not been met in this article: ethical approval by an Institutional
Review Board (IRB) committee or equivalent, patient/participant consent to participate,
and/or agreement to publish patient/participant details (where relevant).
Wiley and Hindawi regrets that the usual quality checks did not identify these issues
before publication and have since put additional measures in place to safeguard research
integrity.
We wish to credit our own Research Integrity and Research Publishing teams and anonymous
and named external researchers and research integrity experts for contributing to
this investigation.
The corresponding author, as the representative of all authors, has been given the
opportunity to register their agreement or disagreement to this retraction. We have
kept a record of any response received.
Objective Since the inefficient cancer management is caused by inaccurate diagnoses, there is a need for minimally invasive method to improve the diagnostic accuracy of non-small-cell lung (NSCLC). This study intended to detect miR-340 and miR-450b-5p levels in plasma from NSCLC patients and to assess the potential values for the prediction of tumor development and prognosis. Methods A GSE64591 dataset included 200 samples (100 early-stage NSCLC patients and 100 noncancer control) aimed to identify a panel of circulating miRNAs in plasma. The levels of miR-340 and miR-450b-5p in plasma from NSCLC patients ( n = 120) and healthy controls ( n = 120) were detected by quantitative real-time polymerase chain reaction (qRT-PCR). The diagnostic and prognostic value of plasma miR-340 and miR-450b-5p were performed using receiver operating curves (ROC), Kaplan-Meier method, and Cox regression analysis. Results miR-450b-5p and miR-340 in plasma was significant difference between early-stage NSCLC patients and noncancer control by searching the GSE64591 dataset. When compared with the healthy controls, the plasma miR-340 was decreased in the NSCLC patients, but the plasma miR-450b-5p was increased. NSCLC patients could be distinguished accurately from healthy controls by the circulating miR-340 and miR-450b-5p with the AUC of 0.740 (95% CI: 0.677~0.804) and of 0.808 (95% CI: 0.754~0.861), respectively. With these two markers, the specificity and sensitivity were 78.33% and 77.5% with the AUC of 0.862. Patients with advanced T, N, and TNM stage demonstrated lower plasma miR-340 and higher plasma miR-450b-5p, and both of them were correlated with the prognosis of NSCLC patients. Furthermore, plasma miR-340 was also negatively correlated with tumor grade. All clinicopathological variables significantly associated to prognosis were T stage, N stage, TNM stage, tumor grade, and plasma levels of miR-340 and miR-450b-5p in univariate Cox regression analysis. The variables that retained their significance in the multivariate model were T stage, plasma miR-340, and plasma miR-450b-5p. Conclusion The plasma levels of miR-340 combined with miR-450b-5p potentially define core biomarker signatures for improving the accuracy of NSCLC diagnosis. Moreover, circulating miR-340 and miR-450b-5p are independent biomarkers of survival in nonmetastatic NSCLC patients.
This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.